Suraksha Diagnostic Ltd

Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with the latest insights into its performance and outlook.

Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 March 2026, providing investors with the latest insights into its performance and outlook.

Suraksha Diagnostic Ltd’s stock price plunged to an all-time low of Rs.224.1 on 30 March 2026, marking a significant milestone in its recent market performance. The healthcare services company has experienced a sustained decline, reflecting a challenging phase in its valuation and trading trends.

For the third consecutive session, Suraksha Diagnostic Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 224.1 on 30 Mar 2026. This marks a 12.11% drop over the last three days, underscoring persistent selling pressure despite some stabilisation in broader market indices.

Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Suraksha Diagnostic Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s Mojo Grade was downgraded from Hold to Sell on 11 August 2025, reflecting deteriorating market sentiment and technical weakness. This article analyses the recent price movements, technical indicator signals, and comparative performance against the broader market to provide a comprehensive view of Suraksha Diagnostic’s current standing.

Suraksha Diagnostic Ltd, a micro-cap player in the healthcare services sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day gain of 1.09%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others remain subdued.

Suraksha Diagnostic Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by deteriorating technical indicators including MACD, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued price action amid a challenging market backdrop.

Suraksha Diagnostic Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend, as reflected in recent price action and technical indicators. Despite a modest day gain of 1.34%, the stock’s broader technical landscape presents a complex picture, with some bullish signals emerging on weekly charts while monthly indicators remain subdued. Investors should carefully analyse these mixed signals amid the company’s ongoing underperformance relative to the Sensex over key timeframes.

Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the most recent insights into the company’s performance and outlook.

Suraksha Diagnostic Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 11 Aug 2025. The stock’s recent price action and technical indicators suggest a transition from a sideways trend to a bearish outlook, reflecting growing investor caution amid broader market pressures.

Suraksha Diagnostic Ltd’s shares declined sharply to a new 52-week low of Rs.227.95 on 2 Mar 2026, marking a significant drop amid a five-day losing streak that has seen the stock fall by 6.56%. This decline comes despite a broader market recovery, with the Sensex rebounding after an initial gap down opening.

Suraksha Diagnostic Ltd, a player in the healthcare services sector, has reached a new all-time low price of Rs. 227.95, marking a significant decline amid a period of sustained underperformance relative to the broader market and its sector peers.

Suraksha Diagnostic Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by changes in its price-to-earnings and price-to-book value ratios. This development comes amid a mixed performance backdrop and evolving market sentiment within the healthcare services sector.

Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with the latest insights into the company’s performance and outlook.